Does the Flu Vaccine Work? What 62% “Effective” Really Means
JAMA has posted today a Viewpoint titled “Influenza Prevention Update: Examining Common Arguments Against Influenza Vaccination.”
In this Viewpoint, the authors (from the Vanderbilt University...
Pharma Sets Record: Number of “Pay-for-Delay” Deals Hits 40 in 2012 Says FTC
According a new Federal Trade Commission (FTC) staff report, in Fiscal Year (FY) 2012, the number of "potentially anticompetitive patent dispute settlements" (aka, "Pay...
Study Reveals Inaccuracy of Smartphone Health Apps
Performance of smartphone applications in assessing melanoma risk is highly variable and 3 of 4 applications incorrectly classified 30 percent or more of melanomas...
The (Near) Future of Digital Pharma: Social, Mobile, Analytics, & the Cloud
A discussion with Philippe Kirby, EUCAN MCM IT Director, MSD (Europe) Inc., who previews his presentation at the upcoming 5th Annual Digital Pharma Europe conference. Kirby also discusses what the near future of pharma digital marketing has in store especially regarding use of the iPad, social media, and analytics in physician detailing.
Bad Pharma: A Cherry Picked NON Evidence-based Critique of Pharma Marketing?
I finally finished reading the 400 plus page book Bad Pharma™ by BenGoldacre, a British physician, whose previous book, Bad Science, was a best...
Team Novo Nordisk: Insulin “Doping” Difficult to Prove
Novo Nordisk has a penchant for teaming up with athletes to help promote its diabetes franchise. You might recall that in the U.S. Novo...
Some “Off-Label” Speech is No Longer Politically Correct
The Supreme Court has ruled that corporations are people protected by the U.S. Constitution and Bill of Rights just like us ordinary folk. That...
AbbVie’s “Drive for Five” Campaign: Innovative, Derivative, and Conflictive?
In reviewing what pharmaceutical trade publications had to say about the industry in 2012, I came across MM&M's "All-Star" winners of the year. Sanofi,...
“Spend Less Money on Sales & Marketing,” Says Novartis Chief Joseph Jimenez
In a video interview with Wall Street Journal, Joseph Jimenez, the CEO of Novartis, said "The industry needs to spend more money on R&D...
A “New” New Year’s Resolution: Keep on a Few Extra Pounds
Almost everyone makes this New Year's resolution: lose weight! I also resolve to lose weight this year. But after seeing the results of a...
